Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2017-04-02 2017-03-13
Drug Identification Number 02382296 02382296
Brand name HEPARIN SODIUM INJECTION USP HEPARIN SODIUM INJECTION USP
Common or Proper name HEPARIN HEPARIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HEPARIN SODIUM HEPARIN SODIUM
Strength(s) 1000UNIT 1000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 10ML 25 x 10ML
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2017-04-01 2017-04-01
Remaining supply date 2017-04-01 2017-04-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontunation of product / Discontinuité du produit Discontunation of product / Discontinuité du produit
Health Canada comments